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LPS  is  one  of  the  pathogen  associated  molecular  patterns  that  activates  Toll-like  receptor  4
(TLR4)  signaling  pathway  eliciting  antiviral  host  responses  in  mammals  although  informa-
tion  on  such  responses  in avian  species  is scarce.  Our  objectives  were  to characterize  the
LPS induced  innate  responses  particularly  the  expression  of LPS  receptors  (TLR4,  CD14)  in
avian  macrophages  and  observe  whether  TLR4  mediated  induction  of  NO can  elicit antivi-
ral response  against  infectious  laryngotracheitis  virus  (ILTV)  replication.  We  found  that
LPS was  capable  of  inducing  the  expression  of TLR4,  CD14  and  NO  production  but  not  the
type 1  interferons  in an  avian  macrophage  cell  line,  MQ-NCSU.  We  also  showed  that  TLR4
mediated  NO  production  can  lead  to  antiviral  response  against  ILTV  replication  when  MQ-
NCSU  cells  were  treated  with  LPS  and  the  resultant  supernatant  was  then  transferred  tooll-like receptor 4 ILTV  replicating  cells  to  assess  antiviral  activity.  Antiviral  activity  of  NO was blocked  by  a
selective  inhibitor,  S-methylisothiourea  sulfhate  that  inhibits  inducible  NO  synthase.  This
observation conﬁrms  that  the  antiviral  activity  is  positively  correlated  with  NO  production.
The data  show  that  LPS  can be a potential  innate  immune  stimulant  that  can  be  used against
ILTV  infection  in  chickens  that  require  further  evaluation  in  vivo.
The Au  © 2013 
. Introduction
TLRs and their downstream signaling components are
ostly conserved in chickens (Lillehoj and Li, 2004; Lynn
t al., 2003; Philbin et al., 2005), except for TLR4 (Keestra
nd van Putten, 2008). In mammals, TLR4 is expressed in
 variety of immune and non-immune cells (Arpaia et al.,
011; Tang et al., 2008). One of the well-characterized
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ligands that binds with TLR4 is LPS derived from gram-
negative bacteria such as Escherichia coli (EC-LPS) and
Salmonella sub type Enteritidis (SE-LPS). LPS recognition
by TLR4 requires the activation of co-receptors such as
CD14 and MD2. Chicken TLR4 and co-receptors, in response
to LPS induce pro-inﬂammatory mediators such as inter-
leukin (IL)-1,  IL-6 and IL-18 and the gaseous free radical
nitric oxide (NO) through nitric oxide synthase (iNOS) acti-
vation (Dil and Qureshi, 2002; Farnell et al., 2003; He et al.,
2006). NO has already been shown to mediate anti-viral
response for avian viruses such as reovirus, herpes virus
of turkey (HVT) and Marek’s disease virus (MDV) (Pertile
Open access under CC BY-NC-SA license.et al., 1996; Xing and Schat, 2000).
Here, we ﬁrst investigated whether EC-LPS and SE-LPS
can increase the expression of LPS receptors, TLR4 and
CD14, in avian macrophages in response to LPS. Secondly,
NC-SA license. 
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we evaluated whether NO in culture supernatants elic-
its antiviral effects against another avian viral infection
other than reovirus, HVT and MDV. We  found that avian
macrophages, MQ-NCSU cells could be stimulated with LPS
to increase in the expression of LPS receptors but not type
1 interferons and to elicit antiviral response against infec-
tious laryngotracheitis virus (ILTV) in a NO dependent way.
2. Materials and methods
2.1. Cells and virus
Avian macrophage cell line, MQ-NCSU was a gift from
Dr. Shayan Sharif (University of Guelph, Canada). Leghorn
male hepatoma line (LMH) and ILTV were purchased from
American Type Culture Collection (ATCC).
2.2. Cell culture
LMH  cells were cultured on 0.1% gelatin (Sigma-Aldrich,
St. Louis, MO,  USA) coated tissue culture plates. The growth
medium for LMH  cells consists of complete Waymouth’s
MB 752/1 medium (Invitrogen, Burlington, ON, Canada).
The MQ-NCSU cells were cultured in complete LM HAHN
medium. The cells were maintained under 5% carbon diox-
ide (CO2) and 37 ◦C (LMH) or 40 ◦C (MQ-NCSU).
2.3. Experimental design
2.3.1. Stimulation of macrophages for quantiﬁcation of
TLR4 and CD14 expression
The MQ-NCSU cells responded to LPS treatment produc-
ing NO in a dose dependent manner (data not shown). The
lowest concentration of LPS (0.1 g/ml) that resulted high
amount of NO in our preliminary studies was chosen for
subsequent experiments. MQ-NSU cells were treated with
either EC-LPS or SE-LPS with un-stimulated controls. Three,
6 and 12 h post-treatment, 2 × 106 cells from each treat-
ment or control stained for TLR4 and CD14 expressions.
The experiment was done in triplicate.
2.3.2. Antiviral assay for culture supernatants produced
following MQ-NCSU stimulation with LPS in vitro
MQ-NCSU cells were cultured in 6 well plates
(2 × 106 cells/well) 24 h before treatments with 0.1 g/ml
EC-LPS, SE-LPS or PBS. 18 h post-treatment culture super-
natants (500 l/well) were collected and transferred to
naive LMH  cells. Then, LMH  cells were infected with
10-fold serial dilution of ILTV (500 l/well) with a
titer of 1.27 × 106 plaque forming unit (PFU)/ml. Five
days following the infection, the number of plaques
was counted. The experiment was done in tripli-
cate.
2.3.3. Determining the antiviral effect of LPS mediated
NO production in vitro
MQ-NCSU cells were cultured in 6 well plates (2 × 106
cells/well) 24 h before treatments with 0.1 g/ml EC-LPS
or SE-LPS with or without inducible nitric oxide syn-
thase (iNOS) inhibitor, S-methylisothiourea sulphate (SMT;
Sigma-Aldrich, St. Louis, MO,  USA) or PBS. Six and 18 hmmunopathology 155 (2013) 270– 275 271
post-treatment culture supernatants were collected and
transferred to naive LMH  cells. Then, LMH  cells were
infected with 100 PFU/well of ILTV. Five days following the
infection, the number of plaques was  counted. The experi-
ment was  done in triplicate.
2.3.4. Stimulation of macrophages for quantiﬁcation of
mRNA expression of type 1 interferons
In chickens, since it has been shown that LPS signaling
does not lead to interferon (IFN) expression in HD11 avian
macrophages (Keestra and van Putten, 2008), we  evaluated
whether LPS signaling in MQ-NCSU avian macrophages
lead to similar outcome to rule out the potential involve-
ment of type 1 interferons as antiviral molecules against
ILTV following LPS stimulation. At this end we quanti-
ﬁed the expressions of IFN and IFN mRNA following
stimulation with SE-LPS (0.1 g/ml) on 0.5, 1, 3, 6, 12
and 24 h post-treatment using real-time PCR as has been
described previously (Esnault et al., 2011; Villanueva et al.,
2011).
2.4. Assay for endotoxin contamination
The LPS concentrations in the used reagents and
all the growth media were determined using Limulus
Amebocyte Lysate LPS detection assay (E-TOXATETM kit;
Sigma-Aldrich, St. Louis, MO,  USA) according to the manu-
facturer’s protocol.
2.5. Assay for NO production
Cell-free culture supernatants were assayed for nitrite,
a stable metabolite of NO, as a measure of NO produc-
tion, using a Griess reagent system (Promega, Madison, WI,
Canada) according to the manufacturer’s recommendation.
The absorbance (OD) of the ﬁnal colorimetric product was
read at 548 nm. The concentration of nitrite was quantiﬁed
using sodium nitrite as a standard.
2.6. Flow cytometry
Standard ﬂow cytometry procedures were used. Brieﬂy,
the isolated MQ-NCSU cells were Fc blocked using 1:100
chicken serum (Invitrogen, Burlington, ON, Canada). Stain-
ing was done at ﬁnal concentration of 0.02 ug/l  mouse
anti-Human CD284 (TLR4) phycoerythrin (PE) mAb (Clone
HTA125, eBioscience, San Diego, CA, USA), or mouse anti-
Human CD14 FITC mAb  (Clone MSE2, eBioscience, San
Diego, CA, USA), with respective isotype controls or 1% BSA
(unstained controls) and incubated on ice for 30 min. The
samples were analyzed with a BD LSR II ﬂow cytometer (BD
Biosciences, Mississauga, ON, Canada).
2.7. Data analysisData were subjected to ANOVA test followed by
Tukey’s test (Minitab Inc., State College, Pennsylvania,
USA). Before being tested, each set of data was analyzed
using the Grubbs’ test (GraphPad Software Inc., CA, USA) to
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Fig. 1. MQ-NCSU cells increase the expression of TLR4 and CD14 following treatment with LPS. The experiment was done in triplicate; (a) a representative
FACS  plot of isotype control for PE- mouse anti-human TLR4 Ab; (b) a representative FACS plot of isotype control for FITC-mouse anti-human CD14 Ab;
(c)  a representative FACS plot showing control TLR4+ CD14+ macrophages; (d)–(e) representative FACS plots showing TLR4+ CD14+ macrophages 12 h
post-treatment with EC-LPS and SE-LPS respectively; (f)–(g) illustrates percentage TLR4+ CD14+ macrophages 3, 6 and 12 h post-treatment with EC-LPS
and  SE-LPS, respectively.
Fig. 2. Culture supernatants of LPS-treated MQ-NCSU cells inhibit ILTV replication in vitro; (a) illustrates representative ILTV titration plates from EC-LPS
and  SE-LPS treated groups compared to the control; (b) illustrates ILTV titers in EC-LPS and SE-LPS treated groups compared to the control.
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Fig. 3. NO produced by MQ-NCSU cells following LPS treatment inhibits ILTV replication in vitro; (a) represents the concentration of NO in cell culture
supernatants 6 h post-treatment; (b) represents the concentration of NO in cell culture supernatants 18 h post-treatment; (c) shows the ILTV titers as a
percentage following transfer of 6 h conditioned media from MQ-NCSU cells; (d) shows the ILTV titers as a percentage following transfer of 18 h conditioned
lates of media from MQ-NCSU cells; (e) illustrates representative ILTV titration p
identify outliers. Comparisons were considered signiﬁcant
at P ≤ 0.05.
3. Results and discussion
First, LPS-TLR4 induced signaling pathway activates
MQ-NCSU chicken macrophages by increasing TLR4 and
CD14 cell surface expression and elicits an antivi-
ral response against ILTV. Secondly, the inhibition of
ILTV replication was dependant on NO production intreatment and control groups. Data represent mean values ± SEM.
supernatants. Finally, we conﬁrmed that SE-LPS stimula-
tion of MQ-NCSU cells does not lead to type 1 interferon
mRNA expression (P > 0.05, Fig. 4) and unlikely to have con-
tributed to the antiviral effect elicited by MQ-NCSU cells
following LPS stimulation against ILTV.
It has been shown that the expression of avian CD14
and TLR4 can be quantiﬁed using anti-human mAbs against
these two  receptors as they are components of highly
conserved innate immune system (Dil and Qureshi, 2002;
Janeway and Medzhitov, 2002). In agreement with these
274 S. Haddadi et al. / Veterinary Immunology and I
Fig. 4. MQ-NCSU cells do not up regulate the mRNA expression of IFN
and IFN following treatment with SE-LPS; (a) and (b) illustrate the IFN
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gnd IFN mRNA expressions, respectively. Real-time PCR was  done to
uantify the mRNA expression and fold changes are presented. Data rep-
esent mean values ± SEM.
bservations, we observed ﬁrst that MQNCSU cells express
LR4 and CD14 constitutively, but in a low number of cells.
ollowing treatment with EC-LPS the expression of TLR4
nd CD14 have been increased signiﬁcantly in MQ-NCSU
ells when compared to the controls at 6 h (P = 0.002) and
2 h (P = 0.002) post-treatments (Fig. 1) whereas with SE-
PS, the MQ-NCSU cells expressing both TLR4 and CD14
ncreased signiﬁcantly at 12 h post stimulation (P = 0.002).
e also observed that culture supernatants collected fol-
owing LPS treatment of MQ-NCSU could reduce ILTV
eplication in susceptible LMH  cells (P = 0.00; Fig. 2).
Xing and Schat (2000) have shown that the inhibition
f MDV  and HVT replication in CEF stimulated by LPS
ollowing recombinant ChIFN- is mediated by NO and
ot any other bioactive agents such as reactive oxygen
pecies, IL-1 and IL-6 like molecules produced follow-
ng the treatment (Xing and Schat, 2000). Pertile et al.
1996) also have shown that NO-mediated antiviral effect
gainst avian reovirus in HD11 cells treated with spleen
ell conditioned-medium or LPS (Pertile et al., 1996). We
bserved that iNOS inhibitor signiﬁcantly reduced the pro-
uction of NO induced by EC-LPS and SE-LPS TLR4 ligands
n MQ-NCSU cells (P = 0.00; Fig. 3a and b). Culture super-
atants produced by MQ-NCSU cells following treatment
ith EC-LPS and iNOS inhibitor (6 h post-treatment) abro-
ated the inhibitory effect of ILTV replication shown bymmunopathology 155 (2013) 270– 275
culture supernatants of MQ-NCSU cells treated with EC-LPS
alone (P = 0.031; Fig. 3c and e). Culture supernatants pro-
duced by MQ-NCSU cells 18 h post-treatment with EC-LPS
or SE-LPS with an iNOS inhibitor abrogated the inhibitory
effect of ILTV replication when compared to MQ-NCSU cells
treated with EC-LPS and SE-LPS alone (P = 0.000; Fig. 3d and
e).
The viability of the cells in our experiments was  more
than 95% according to trypan blue exclusion. Endotoxin
concentrations of all the tested reagents were below
0.06 EU/ml.
The method we used for NO quantiﬁcation, Griess assay
detects nitrite and not NO. For this reason we  could not
relate our antiviral effect ﬁndings directly to NO. Since NO
is unstable, it is possible that by the time of treatment of
LMH  cells, NO may  have converted to nitrite. Unlike NO,
nitrite is stable and unlikely to possess antiviral activity. It
has also been shown that under certain conditions nitrite
can convert back to NO in biological systems (Lundberg
et al., 2008). It is a potential reason for the observed antivi-
ral effect in our experiments, however, this needs further
investigation.
In conclusion, we  have shown that EC-LPS and SE-LPS
TLR4 ligands are capable of activating MQ-NCSU avian
macrophages as evidenced by increase of LPS receptors
and elicit antiviral response against ILTV in a NO depend-
ent manner. The potential role of type 1 interferons in LPS
mediated antiviral response against ILTV is not clear since
we  did not observe up regulation of expressions of IFN and
IFN following SE-LPS treatment. It is of interest to investi-
gate the interaction between E. coli and ILTV in respiratory
mucosa.
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